Clinical trial
Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder
NCT00109577 · University of Calgary, Other · Terminated
Key facts
| NCT number | NCT00109577 |
|---|---|
| Title | Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder |
| Official title | Randomized Placebo-controlled Phase II Trial of MCN36 in Adults With Bipolar Disorder |
| Lead sponsor | University of Calgary, Other |
| Collaborators | Alberta Innovation and Science |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | MCN36 (nutritional supplement), Placebo |
| Enrollment | 40 |
| Start date | Apr 1, 2005 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Apr 29, 2005 |
| Last update posted | Sep 18, 2012 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: